secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2021-12-16T23:59:59+00:00
Accession:  0001104659-21-150570
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Robert A. Michael appointed Vice Chairman, Finance and Commercial Operations and CFO
--------------------------------------------------------------------------------

- Effective December 16, 2021, Robert A. Michael, 51, named Vice Chairman, Finance and Commercial Operations and CFO.
- Michael previously served as Executive Vice President, CFO since October 2018 and held prior roles including VP Controller and VP Treasurer.
- He joined Abbott Laboratories in 1993 and held various finance positions before AbbVie's formation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465921150570/0001104659-21-150570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465921150570/tm2135667d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-150570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer